Electroacupuncture Reduces Myocardial Ischemia-Reperfusion Injury

Overview

This study demonstrates that electroacupuncture (EA) mitigates myocardial ischemia-reperfusion injury (MIRI) by inhibiting NLRP3 inflammasome-mediated cardiomyocyte pyroptosis through the upregulation of serum exosomal miR-22-3p.

Background

Myocardial ischemia-reperfusion injury (MIRI) is a significant complication following reperfusion therapy in acute myocardial infarction, leading to further myocardial damage. The NLRP3 inflammasome plays a critical role in mediating cardiomyocyte pyroptosis, contributing to the pathophysiology of MIRI.

Data Highlights

Key Findings

• Electroacupuncture significantly reduces myocardial infarction area and improves cardiac function in MIRI models.
• EA inhibits NLRP3 inflammasome-mediated cardiomyocyte pyroptosis.
• Serum exosomes from EA-treated subjects show increased levels of miR-22-3p.
• miR-22-3p targets NLRP3 to mitigate myocardial injury.
• Western blotting and RT-qPCR confirm the downregulation of NLRP3-related apoptosis markers following EA.

Clinical Implications

Clinicians may consider the role of serum exosomal miR-22-3p as a potential biomarker for assessing the efficacy of interventions targeting MIRI.

Conclusion

Electroacupuncture demonstrates a protective effect against myocardial ischemia-reperfusion injury by modulating the NLRP3 inflammasome pathway through serum exosomal miR-22-3p.

Related Resources & Content

1. Frontiers | Electroacupuncture alleviates myocardial ischemia-reperfusion injury by targeting and inhibiting NLRP3 inflammasome-mediated cardiomyocyte pyroptosis via serum exosomal miR-22-3p
2. Frontiers in Neurology — Exosomal lncRNA MIAT enriched in M2 macrophages contributes to electroacupuncture-driven peripheral nerve regeneration through targeting MiR-130a-3p/KLF7
3. Frontiers in Immunology — The immune-cardiovascular metabolic circuitry in myocardial ischemia-reperfusion injury: from metabolic signal release to spatiotemporal reprogramming
4. Basic Research in Cardiology — Targeting Inflammatory Cells and Their Non-Coding RNAs for Myocardial Infarction Treatment
5. Basic Research in Cardiology — Exploring Extracellular Vesicle-Derived MicroRNAs: A Comparison of Cardioprotection and Regeneration
6. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | JACC
7. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial - PMC
8. Canakinumab Anti-Inflammatory Thrombosis Outcomes Study - American College of Cardiology
9. Pyroptosis in myocardial ischemia/reperfusion and its therapeutic implications - ScienceDirect
10. Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure - PMC
11. Reperfusion Injury in Patients With Acute Myocardial Infarction: JACC Scientific Statement - ScienceDirect
12. Frontiers | Electroacupuncture alleviates myocardial ischemia-reperfusion injury by targeting and inhibiting NLRP3 inflammasome-mediated cardiomyocyte pyroptosis via serum exosomal miR-22-3p
13. Frontiers | Electroacupuncture Pretreatment Mitigates Myocardial Ischemia/Reperfusion Injury via XBP1/GRP78/Akt Pathway
14. Frontiers | Electroacupuncture for slow flow/no-reflow in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a pilot randomized controlled trial